Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.35 EUR | -0.87% | +0.13% | -18.67% |
Apr. 30 | Bayer: strategic collaboration with Evotec | CF |
Apr. 30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.67% | 28.73B | |
+33.67% | 704B | |
+28.38% | 577B | |
-4.90% | 348B | |
+17.44% | 327B | |
+4.48% | 288B | |
+14.94% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.97% | 147B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation